Cargando…

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients

Intensity modulated radiotherapy (IMRT) is one of the modern conformal radiotherapies that is widely used within the context of cancer patient treatment. It uses multiple radiation beams targeted to the tumor, however, large volumes of the body receive low doses of irradiation. Using γ-H2AX and glob...

Descripción completa

Detalles Bibliográficos
Autores principales:	EL-SAGHIRE, HOUSSEIN, VANDEVOORDE, CHARLOT, OST, PIET, MONSIEURS, PIETER, MICHAUX, ARLETTE, DE MEERLEER, GERT, BAATOUT, SARAH, THIERENS, HUBERT
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977809/ https://www.ncbi.nlm.nih.gov/pubmed/24435511 http://dx.doi.org/10.3892/ijo.2014.2260

Ejemplares similares

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
por: Fonteyne, Valérie, et al.
Publicado: (2012)

The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study
por: Poelaert, Filip, et al.
Publicado: (2015)

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
por: De Wolf, Katrien, et al.
Publicado: (2015)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
por: Fonteyne, Valérie, et al.
Publicado: (2017)

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial
por: Draulans, Cédric, et al.
Publicado: (2018)

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
por: Konings, Katrien, et al.
Publicado: (2020)

Carbon ion irradiation of the human prostate cancer cell line PC3: A whole genome microarray study
por: SUETENS, ANNELIES, et al.
Publicado: (2014)

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy
por: Danckaert, Willeke, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Planet survival, pro and con
Publicado: (2008)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
por: Decaestecker, Karel, et al.
Publicado: (2014)

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
por: Crippa, Alessio, et al.
Publicado: (2020)

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer
por: De Bleser, Elise, et al.
Publicado: (2020)

Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2022)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

PREDICT: model for prediction of survival in localized prostate cancer
por: Kerkmeijer, Linda G. W., et al.
Publicado: (2015)

Pro-death and pro-survival properties of ouabain in U937 lymphoma derived cells
por: Cuozzo, Francesca, et al.
Publicado: (2012)

Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment
por: Hosseini-Beheshti, Elham, et al.
Publicado: (2016)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
por: Egan, Karl, et al.
Publicado: (2011)

A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer
por: De Kerf, Geert, et al.
Publicado: (2023)

Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy
por: De Langhe, Sofie, et al.
Publicado: (2014)

The RNA-Binding Protein ProQ Promotes Antibiotic Persistence in Salmonella
por: Rizvanovic, Alisa, et al.
Publicado: (2022)

Adaptation to ER Stress Is Mediated by Differential Stabilities of Pro-Survival and Pro-Apoptotic mRNAs and Proteins
por: Rutkowski, D. Thomas, et al.
Publicado: (2006)

HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts
por: Trapella, Claudio, et al.
Publicado: (2018)

Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index
por: Rancoule, Chloé, et al.
Publicado: (2017)

ProCOC: The prostate cancer outcomes cohort study
por: Umbehr, Martin, et al.
Publicado: (2008)

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores
por: Maltoni, Marco, et al.
Publicado: (2022)

Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
por: Zilli, Thomas, et al.
Publicado: (2018)

p53: Pro-aging or pro-longevity?
por: de Keizer*, Peter L.J., et al.
Publicado: (2010)

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol
por: Pasquier, David, et al.
Publicado: (2018)

Elevated level of inhibin-α subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer
por: Balanathan, P, et al.
Publicado: (2009)

MRE11 and ATM AKTivate pro-survival signaling
por: Golding, Sarah E., et al.
Publicado: (2011)

Caveolins: targeting pro-survival signaling in the heart and brain
por: Stary, Creed M., et al.
Publicado: (2012)

How worms survive desiccation: Trehalose pro water
por: Erkut, Cihan, et al.
Publicado: (2012)

Pro‐tumorigenic role of ERα in prostate cancer cells
por: Furic, Luc, et al.
Publicado: (2015)

From PROMIS to PRO-MRI in primary prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2017)

Intensity-modulated radiotherapy for prostate cancer
por: Fischer-Valuck, Ben W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1gqda4m2vpsntg4o3cbabg3et